AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Research: Combination chemotherapy reduces ovarian cancer tumor mass.
2003 JUL 3 - (NewsRx.com & NewsRx.net) -- Researchers from Yale University School of Medicine presented data indicating that phenoxodiol, a synthetic anticancer compound manufactured by Novogen Limited, when added to low levels of standard chemotherapy agents, produces dramatic reductions in the size of human ovarian cancer tumors in animals.
The data were presented at the annual meeting of the American Society of Clinical Oncology.
The Yale researchers previously have shown that phenoxodiol was the most effective drug in the test tube in killing ovarian cancer cells that were resistant to standard chemotherapeutics. The new data is an important development in showing that this potent anticancer effect of phenoxodiol is retained in vivo.
In a further development, the Yale researchers also showed that phenoxodiol had the ability to render ovarian cancer cells more susceptible to the ...
- New ovarian cancer research from Yale University, Medical Department outlined.
- Newspaper article from: Cancer Weekly July 14, 2009 700+ words
...colleagues, Yale University, Medical Department...Detection of Ovarian Cancer. Clinics in...contact G. Mor, Yale University, School Medical...Oncology, Ovarian Cancer, Ovarian Carcinoma...s Health, Yale University, Medical Department...
- Investigational Anti-Cancer Drug, Phenoxodiol, Produces Promising Results in...
- Press release article from: PR Newswire February 9, 2004 700+ words
Researchers from Yale University School of Medicine...women with recurrent ovarian cancer using phenoxodiol...responsiveness of ovarian cancer cells to standard...the ability to stop ovarian cancer growth in animals...
- Studies in the area of ovarian cancer reported from Yale University.
- Newspaper article from: Blood Weekly September 3, 2009 700+ words
...colleagues, Yale University (see also Ovarian Cancer). The researchers...Epithelial Ovarian Cancer Implications...Santin, Yale University, Dept...Oncology, Ovarian Cancer, Ovarian...Health, Yale University. This article...
- New Clinical Study of Phenoxodiol as Chemo-sensitizer for Docetaxel in Ovarian...
- Press release article from: PR Newswire November 28, 2005 700+ words
...women with recurrent ovarian cancer. The investigator...take place at the Yale University School of Medicine...recurrent or persistent ovarian cancer that have failed...women with recurrent ovarian cancer. The study will...
- New findings from Yale University, Medical Department in the area of ovarian...
- Newspaper article from: Cancer Weekly October 6, 2009 700+ words
...colleagues, Yale University, Medical Department (see also Ovarian Cancer). The researchers...Paclitaxel in Type I ovarian cancer cells. Journal...contact G. Mor, Yale University, School Medical...Oncology, Ovarian Cancer, Ovarian Carcinoma...s Health, ...
- Marshall Edwards Inc. Begins Trial of Phenoxodiol at Yale University School of...
- Press release article from: PR Newswire December 10, 2002 700+ words
...establishment at Yale University School of Medicine...national study. Yale University is the only...cell death in ovarian cancer cells that...laboratories at Yale University School of Medicine...at killing ovarian cancer cells that...
- Researchers from Yale University, Medical Department report details of new...
- Newspaper article from: Blood Weekly May 7, 2009 700+ words
...colleagues, Yale University, Medical Department...in advanced ovarian cancer by using automated...Psyrri, Yale University, School Medical...Oncology, Ovarian Cancer, Ovarian Carcinoma...s Health, Yale University, Medical Department...
- Ovarian Cancer Researchers at Yale Win Millions in Federal and Foundation...
- Press release article from: M2 Presswire January 23, 2009 700+ words
...PRESSWIRE-23 January 2009-Yale University: Ovarian Cancer Researchers at Yale Win...detected in many women, ovarian cancer has already spread to a...their efforts to improve ovarian cancer detection and find a cure...
Source: HighBeam Research, Research: Combination chemotherapy reduces ovarian cancer tumor mass.